R‐roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic …

M Rogalińska, JZ Błoński, O Komina… - Journal of cellular …, 2010 - Wiley Online Library
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of malignant,
apoptosis‐resistant B CD19+/CD5+ cells. Populations of CLL cells are heterogeneous and …
被引用次数：22 相关文章

R‐roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic …

M Rogalińska, JZ Błoński, O Komina, P Góralski… - Journal of Cellular …, 2009 - infona.pl
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of malignant,
apoptosis‐resistant B CD19+/CD5+ cells. Populations of CLL cells are heterogeneous and …
[PDF] researchgate.net

[PDF][PDF] R-Roscovitine (Seliciclib) Affects CLL Cells More Strongly Than Combinations of Fludarabine or Cladribine With Cyclophosphamide: Inhibition of CDK7 …

M Rogalinska, JZ Błonski, O Komina… - Journal of Cellular …, 2010 - researchgate.net
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of malignant,
apoptosis-resistant B CD19þ/CD5þ cells. Populations of CLL cells are heterogeneous and …

R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic …

M Rogalińska, JZ Błoński, O Komina… - Journal of Cellular …, 2010 - europepmc.org
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of malignant,
apoptosis-resistant B CD19 (+)/CD5 (+) cells. Populations of CLL cells are heterogeneous …

R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic …

M Rogalińska, JZ Błoński, O Komina… - Journal of cellular …, 2010 - pubmed.ncbi.nlm.nih.gov
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of malignant,
apoptosis-resistant B CD19 (+)/CD5 (+) cells. Populations of CLL cells are heterogeneous …

[引用][C] R―Roscovitine (Seliciclib) Affects CLL Cells More Strongly Than Combinations of Fludarabine or Cladribine With Cyclophosphamide: Inhibition of CDK7 …

M ROGALINSKA, JZ BLONSKI, O KOMINA… - Journal of cellular …, 2010 - Wiley-Liss